PartsTable
Technical Data Sheet
Download PDF

NDC00085-0584-01 — THEOPHYLLINE EXTENDED-RELEASE TA

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC00085-0584-01: THEOPHYLLINE EXTENDED-RELEASE TA.

THEOPHYLLINE EXTENDED-RELEASE TA. Key specifications include primary_container_type: BOTTLE, therapeutic_equivalent: THEO-DUR BY SCHERING, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG 100S BT. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-037-5607, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00085-0584-01
NSN: 6505-01-037-5607
FSC: 6505 — Drugs and Biologicals
CAGE: 1F095 — SCHERING-PLOUGH CORPORATION (USA)
SPECIFICATIONS
primary_container_typeBOTTLE
therapeutic_equivalentTHEO-DUR BY SCHERING
primary_container_content_quantity100.000 TABLETS
active_medicament_medicinal_strength300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyTHEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG 100S BT
NSN6505-01-037-5607
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available THEOPHYLLINE EXTENDED-RELEASE TA TITLE COMPONENT PN NDC00085-0584-01 MFR THEOPHYLLINE EXTENDED-
KEY FEATURES
•
THERAPEUTIC EQUIVALENT: THEO-DUR BY SCHERING
•
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
•
PRIMARY CONTAINER TYPE: BOTTLE
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
TECHNICAL CHARACTERISTICS
THERAPEUTIC EQUIVALENTTHEO-DUR BY SCHERING
PRIMARY CONTAINER CONTENT QUANTITY100.000 TABLETS
PRIMARY CONTAINER TYPEBOTTLE
PART NAME ASSIGNED BY CONTROLLING AGENCYTHEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG 100S BT
ACTIVE MEDICAMENT MEDICINAL STRENGTH300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
SUBSTITUTES & CROSS-REFERENCES 4
NDC00258-3581-01Reference document
Same NSN cross-reference
Reference document — Secondary reference
THEO-DURReference document
Same NSN cross-reference
Reference document — Secondary reference
NDC00603-5946-21Reference document
Same NSN cross-reference
Reference document — Secondary reference
THEO-DUR TABLETSReference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusCancelled· U.S. Government catalog
HAZMAT per U.S. Government catalogShelf-life managedNo demilitarization required
Ready to buy NDC00085-0584-01?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00085-0584-01?
NDC00085-0584-01 is a THEOPHYLLINE EXTENDED-RELEASE TA.
What parts can replace NDC00085-0584-01?
There are 4 known substitutes for NDC00085-0584-01: NDC00258-3581-01, THEO-DUR, NDC00603-5946-21 and 1 more. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00085-0584-01?
NDC00085-0584-01 is cataloged in the U.S. Government catalog under NSN 6505-01-037-5607. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00085-0584-01